BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15310009)

  • 1. Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia.
    Tayeb MT; Clark C; Murray GI; Sharp L; Haites NE; McLeod HL
    Ann Saudi Med; 2004; 24(1):21-6. PubMed ID: 15310009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in CAG and GGN repeat lengths and CAG/GGN haplotype in androgen receptor gene polymorphism and prostate carcinoma in Nigerians.
    Akinloye O; Gromoll J; Simoni M
    Br J Biomed Sci; 2011; 68(3):138-42. PubMed ID: 21950206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.
    Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
    Saudi Med J; 2004 Apr; 25(4):447-51. PubMed ID: 15083213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians.
    Giovannucci E; Stampfer MJ; Chan A; Krithivas K; Gann PH; Hennekens CH; Kantoff PW
    Prostate; 1999 May; 39(2):130-4. PubMed ID: 10221569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer.
    Tan JSJ; Ong KC; Ong DBL; Wu YS; Razack A; Kuppusamy S; Lim J; Rhodes A
    Malays J Pathol; 2019 Dec; 41(3):243-251. PubMed ID: 31901908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor CAG polymorphism and prostate cancer risk.
    Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
    Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of androgen receptor CAG repeats with the risks of benign prostatic hyperplasia and prostate cancer: a meta-analysis].
    Wang XM; Sun L; Zhang Z; Shi XH; Zhang YG; Wei D; Wan B; Yang Z; Wang JY
    Zhonghua Nan Ke Xue; 2014 Feb; 20(2):172-6. PubMed ID: 24520673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia.
    Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
    Br J Cancer; 2003 Mar; 88(6):928-32. PubMed ID: 12644831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth.
    Mitsumori K; Terai A; Oka H; Segawa T; Ogura K; Yoshida O; Ogawa O
    Prostate; 1999 Dec; 41(4):253-7. PubMed ID: 10544298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The androgen receptor gene GGN microsatellite and prostate cancer risk.
    Platz EA; Giovannucci E; Dahl DM; Krithivas K; Hennekens CH; Brown M; Stampfer MJ; Kantoff PW
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):379-84. PubMed ID: 9610786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
    Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
    Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic repeats in the androgen receptor gene in high-risk sibships.
    Miller EA; Stanford JL; Hsu L; Noonan E; Ostrander EA
    Prostate; 2001 Aug; 48(3):200-5. PubMed ID: 11494335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues.
    Sircar K; Gottlieb B; Alvarado C; Aprikian A; Beitel LK; Alam-Fahmy M; Begin L; Trifiro M
    Prostate Cancer Prostatic Dis; 2007; 10(4):360-8. PubMed ID: 17440439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer.
    Das K; Cheah PY; Lim PL; Zain YB; Stephanie FC; Zhao Y; Cheng C; Lau W
    Cancer Lett; 2008 Sep; 268(2):340-7. PubMed ID: 18495332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
    Soni A; Bansal A; Mishra AK; Batra J; Singh LC; Chakraborty A; Yadav DS; Mohanty NK; Saxena S
    Genet Test Mol Biomarkers; 2012 Aug; 16(8):835-40. PubMed ID: 22731640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
    Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
    Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene.
    Li C; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber JE; Larsson C; Ekman P
    Int J Mol Med; 2003 Apr; 11(4):529-33. PubMed ID: 12632109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.
    Kristal AR; Price DK; Till C; Schenk JM; Neuhouser ML; Ockers S; Lin DW; Thompson IM; Figg WD
    Prostate; 2010 May; 70(6):584-90. PubMed ID: 19938041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.
    Weng H; Li S; Huang JY; He ZQ; Meng XY; Cao Y; Fang C; Zeng XT
    Sci Rep; 2017 Jan; 7():40554. PubMed ID: 28091563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.